SRT-100™: The Doctor’s Choice for Treatment of Non-Melanoma Basal Cell Cancer

Giving a skin cancer diagnosis to a patient is never easy. The word 'cancer' is a scary word for any

patient to hear. Sadly, one in five Americans will develop skin cancer over the course of their

lifetime and 40 to 50 percent of Americans who live to age 65 will have either basal cell carcinoma

or squamous cell carcinoma at least once. Basal cell cancer is the most common form of skin

cancer.

While patients facing basal cell cancer have multiple choices available for the treatment of their

skin cancer, are you offering your patients the best treatment available? The majority of treatment

options for basal cell cancer involve a surgical procedure of some type, whether excisional surgery,

electrosurgery, cryosurgery, laser surgery or Mohs micrographic surgery.

What if you could provide your patients facing skin cancer with a treatment option that is painless,

safe and effective to treat his or her basal cell carcinoma?

The SRT-100™ is that option.

Sensus Healthcare's SRT-100™ delivers a precise, calibrated dose of Superficial Radiation Therapy

that only goes skin deep. This low-dose of radiation safely destroys non-melanoma skin cancer

(such as basal cell carcinoma) without damaging healthy surrounding tissue. There is no need for

anesthesia, no cutting or stitching, less risk for infection, and no need for patients to undergo

reconstructive plastic surgery to repair surgical scars. With the SRT-100™, patients heal quickly

from their basal cell cancer treatment with no downtime or lifestyle restrictions following the

procedure.

Performed right in your office, Superficial Radiation Therapy with the SRT-100™ delivers optimum

results to treat basal cell carcinoma without the negative side effects of invasive treatments. This

treatment is ideal for your patients diagnosed with basal cell carcinoma who also have health risks

that prevent them from undergoing surgical treatment, or patients who wish to avoid the pain and

scarring associated with surgery.

For the physician, SRT-100™ offers many unique features including: broad range of motion;

compact, mobile design; precise and accurate x-ray delivery; variable applicator sizes; and

replaceable contact shields.

Sensus Healthcare's SRT-100™ has cure rates comparable to those of surgical skin cancer

treatment options and has been cleared by the U.S. Food and Drug Administration for the

treatment of basal cell carcinoma. It is ideal for private dermatology and oncology practices, as

well as hospitals and multi-locale healthcare providers.

Give your patients a non-surgical, painless and effective basal cell cancer treatment. Contact

Sensus Healthcare today to learn more about the SRT-100™.